{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:05:12Z","timestamp":1790611512453,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Splenic switch-off (SSO) is defined as a decrease in splenic radiotracer uptake following pharmacological stress. This study aimed to assess the clinical utility of SSO on adenosine triphosphate (ATP) <jats:sup>13<\/jats:sup>N-ammonia positron emission tomography (PET) in patients without coronary artery disease (CAD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>We analyzed 63 patients (mean age, 67\u2009\u00b1\u200911\u00a0years; 34 males) who underwent ATP <jats:sup>13<\/jats:sup>N-ammonia PET without significant CAD on invasive coronary angiography or cardiac computed tomography within 6\u00a0months. Visual assessment of the SSO was conducted by two independent observers, with disagreements resolved by a third observer. We divided the patients into two groups according to the presence (positive) or absence (negative) of SSO and compared global myocardial flow reserve (MFR) and myocardial blood flow (MBF) between the two groups. In addition, the relationship between the reduced MFR and SSO was investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Negative SSO was observed in 15 of 63 patients. Global MFR and global stress MBF were significantly higher in the positive SSO group than in the negative SSO group (2.4\u2009\u00b1\u20090.6 vs. 1.6\u2009\u00b1\u20090.6, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, and 2.3\u2009\u00b1\u20090.5 vs. 1.5\u2009\u00b1\u20090.5\u00a0ml\u00a0min<jats:sup>\u22121<\/jats:sup>\u00a0g<jats:sup>\u22121<\/jats:sup>, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, respectively). Global rest MBF showed no significant difference between the two groups (1.0\u2009\u00b1\u20090.2 vs. 1.0\u2009\u00b1\u20090.3\u00a0ml\u00a0min<jats:sup>\u22121<\/jats:sup>\u00a0g<jats:sup>\u22121<\/jats:sup>, <jats:italic>P<\/jats:italic>\u2009=\u20090.80). In the negative SSO group, 12 of the 15 (80%) patients had a reduced MFR (&lt;2.0). In contrast, in the positive SSO group, 15 of the 48 (31.3%) patients had a reduced MFR, which was suggestive of coronary microvascular dysfunction (CMD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The presence of a splenic response based on the visual assessment of SSO may be used to identify an adequate pharmacological response. This can affect the diagnosis of CMD in patients with reduced MFR without CAD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Secondary abstract<\/jats:title>\n            <jats:p>This study showed the clinical utility of splenic switch-off in adenosine triphosphate <jats:sup>13<\/jats:sup>N-ammonia positron emission tomography in patients without coronary artery disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11604-025-01762-0","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T13:51:07Z","timestamp":1743429067000},"page":"1186-1196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical significance of splenic switch-off in adenosine triphosphate 13N-ammonia positron emission tomography in patients without coronary artery disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Kentaro","family":"Ohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhito","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"1762_CR1","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1007\/s12350-022-03158-3","volume":"30","author":"JM Saad","year":"2023","unstructured":"Saad JM, Ahmed AI, Han Y, El Nihum LI, Alahdab F, Nabi F, et al. Splenic switch-off in regadenoson 82Rb-PET myocardial perfusion imaging: assessment of clinical utility. J Nucl Cardiol. 2023;30:1484\u201396.","journal-title":"J Nucl Cardiol"},{"key":"1762_CR2","first-page":"3","volume":"30","author":"RA Reeves","year":"2021","unstructured":"Reeves RA, Halpern EJ, Rao VM. Cardiac imaging trends from 2010 to 2019 in the medicare population. Radiol Cardiothorac Imaging. 2021;30:3.","journal-title":"Radiol Cardiothorac Imaging"},{"key":"1762_CR3","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.jacc.2023.08.027","volume":"82","author":"KK Patel","year":"2023","unstructured":"Patel KK, McGhie AI, Kennedy KF, Thompson RC, Spertus JA, Sperry BW, et al. Impact of positron emission tomographic myocardial perfusion imaging on patient selection for revascularization. J Am Coll Cardiol. 2023;82:1662\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"1762_CR4","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2967\/jnumed.120.246280","volume":"61","author":"TH Schindler","year":"2020","unstructured":"Schindler TH, Bateman TM, Berman DS, Chareonthaitawee P, De Blanche LE, Dilsizian V, et al. Appropriate use criteria for PET myocardial perfusion imaging. J Nucl Med. 2020;61:1221\u201365.","journal-title":"J Nucl Med"},{"key":"1762_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.semnuclmed.2014.05.003","volume":"44","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Di Carli MF. Cardiac PET perfusion: prognosis, risk stratification, and clinical management. Semin Nucl Med. 2014;44:344\u201357.","journal-title":"Semin Nucl Med"},{"key":"1762_CR6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s12350-020-02448-y","volume":"29","author":"A Bakula","year":"2022","unstructured":"Bakula A, Patriki D, von Felten E, Benetos G, Sustar A, Benz DC, et al. Splenic switch-off as a novel marker for adenosine response in nitrogen-13 ammonia PET myocardial perfusion imaging: cross-validation against CMR using a hybrid PET\/MR device. J Nucl Cardiol. 2022;29:1205\u201314.","journal-title":"J Nucl Cardiol"},{"key":"1762_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12968-020-00696-y","volume":"23","author":"D Patriki","year":"2021","unstructured":"Patriki D, von Felten E, Bakula A, Giannopoulos AA, Kamani CH, Schwyzer M, et al. Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET\/CMR scanner. J Cardiovasc Magn Reson. 2021;23:3.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1762_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13550-023-01045-7","volume":"13","author":"SI Inkinen","year":"2023","unstructured":"Inkinen SI, Hippel\u00e4inen E, Uusitalo V. Adenosine-induced splenic switch-off on [15O]H2O PET perfusion for the assessment of vascular vasodilatation. EJNMMI Res. 2023;13:96.","journal-title":"EJNMMI Res"},{"key":"1762_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1213\/00000539-198903000-00014","volume":"68","author":"MW Rooney","year":"1989","unstructured":"Rooney MW, Crystal GJ, Salem MR, Paulissian R. Influence of nifedipine on systemic and regional hemodynamics during adenosine-induced hypotension in dogs. Anesth Analg. 1989;68:261\u20139.","journal-title":"Anesth Analg"},{"key":"1762_CR10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1148\/radiol.2015142059","volume":"276","author":"C Manisty","year":"2015","unstructured":"Manisty C, Ripley DP, Herrey AS, Captur G, Wong TC, Petersen SE, et al. Splenic switch-off: a tool to assess stress adequacy in adenosine perfusion cardiac MR imaging. Radiology. 2015;276:732\u201340.","journal-title":"Radiology"},{"key":"1762_CR11","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/ehjci\/jew205","volume":"18","author":"A Hosking","year":"2017","unstructured":"Hosking A, Koulouroudias M, Zemrak F, Moon JC, Rossi A, Lee A, et al. Evaluation of splenic switch off in a tertiary imaging centre: validation and assessment of utility. Eur Heart J Cardiovasc Imaging. 2017;18:1216\u201321.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1762_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jmri.28460","volume":"58","author":"V Aramend\u00eda-Vidaurreta","year":"2023","unstructured":"Aramend\u00eda-Vidaurreta V, Solis-Barquero SM, Ezponda A, Vidorreta M, Echeverria-Chasco R, Pascual M, et al. Assessment of splenic switch-off with arterial spin labeling in adenosine perfusion cardiac MRI. J Magn Reson Imaging. 2023;58:147\u201356.","journal-title":"J Magn Reson Imaging"},{"key":"1762_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1253\/circj.CJ-17-0745","volume":"82","author":"N Kawaguchi","year":"2018","unstructured":"Kawaguchi N, Okayama H, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, et al. Clinical usefulness of coronary flow reserve ratio for the detection of significant coronary artery disease on 13N-ammonia positron emission tomography. Circ J. 2018;82:486\u201393.","journal-title":"Circ J"},{"key":"1762_CR14","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1161\/01.CIR.91.12.2891","volume":"15","author":"J Czernin","year":"1995","unstructured":"Czernin J, Sun K, Brunken R, B\u00f6ttcher M, Phelps M, Schelbert H. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation. 1995;15:2891\u20137.","journal-title":"Circulation"},{"key":"1762_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00259-002-0818-1","volume":"29","author":"Y Iwado","year":"2002","unstructured":"Iwado Y, Yoshinaga K, Furuyama H, Ito Y, Noriyasu K, Katoh C, et al. Decreased endothelium-dependent coronary vasomotion in healthy young smokers. Eur J Nucl Med Mol Imaging. 2002;29:984\u201390.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1762_CR16","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/0735-1097(90)90237-J","volume":"15","author":"GD Hutchins","year":"1990","unstructured":"Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032\u201342.","journal-title":"J Am Coll Cardiol"},{"key":"1762_CR17","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2967\/jnumed.111.101840","volume":"53","author":"M Fiechter","year":"2012","unstructured":"Fiechter M, Ghadri JR, Gebhard C, Fuchs TA, Pazhenkottil AP, Nkoulou RN, et al. Diagnostic value of 13N-ammonia myocardial perfusion PET: added value of myocardial flow reserve. J Nucl Med. 2012;53:1230\u20134.","journal-title":"J Nucl Med"},{"key":"1762_CR18","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s12350-018-1269-9","volume":"26","author":"K Bami","year":"2019","unstructured":"Bami K, Tewari S, Guirguis F, Garrard L, Guo A, Hossain A, et al. Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging. J Nucl Cardiol. 2019;26:1888\u201397.","journal-title":"J Nucl Cardiol"},{"key":"1762_CR19","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2022. https:\/\/www.Rproject.org\/."},{"key":"1762_CR20","first-page":"78","volume":"30","author":"M Gulati","year":"2021","unstructured":"Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR Guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;30:78.","journal-title":"J Am Coll Cardiol"},{"key":"1762_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1532-429X-12-66","volume":"12","author":"T Karamitsos","year":"2010","unstructured":"Karamitsos T, Ntusi N, Francis J, Holloway C, Myerson S, Neubauer S. Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:66.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1762_CR22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1007\/s12350-022-03144-9","volume":"30","author":"E Zampella","year":"2023","unstructured":"Zampella E, Mannarino T, D\u2019Antonio A, Assante R, Gaudieri V, Buongiorno P, et al. Prediction of outcome by 82Rb PET\/CT in patients with ischemia and nonobstructive coronary arteries. J Nucl Cardiol. 2023;30:1110\u20137.","journal-title":"J Nucl Cardiol"},{"key":"1762_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jacasi.2023.01.004","volume":"3","author":"D Hwang","year":"2023","unstructured":"Hwang D, Park SH, Koo BK. Ischemia with nonobstructive coronary artery disease: concept, assessment, and management. JACC Asia. 2023;3:169\u201384.","journal-title":"JACC Asia"},{"key":"1762_CR24","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","volume":"78","author":"MG Del Buono","year":"2021","unstructured":"Del Buono MG, Montone RA, Camilli M, Carbone S, Narula J, Lavie CJ, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78:1352\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"1762_CR25","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","volume":"72","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72:2625\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"1762_CR26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jcmg.2022.12.015","volume":"16","author":"TH Schindler","year":"2023","unstructured":"Schindler TH, Fearon WF, Pelletier-Galarneau M, Ambrosio G, Sechtem U, Ruddy TD, et al. Myocardial perfusion PET for the detection and reporting of coronary microvascular dysfunction: a JACC: cardiovascular imaging expert panel statement. JACC Cardiovasc Imaging. 2023;16:536\u201348.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1762_CR27","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","volume":"129","author":"VL Murthy","year":"2014","unstructured":"Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518\u201327.","journal-title":"Circulation"},{"key":"1762_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.114.011939","volume":"131","author":"VR Taqueti","year":"2015","unstructured":"Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131:19\u201327.","journal-title":"Circulation"},{"key":"1762_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014954","volume":"9","author":"MA Gdowski","year":"2020","unstructured":"Gdowski MA, Murthy VL, Doering M, Monroy-Gonzalez AG, Slart R, Brown DL. Association of isolated coronary microvascular dysfunction with mortality and major adverse cardiac events: a systematic review and meta-analysis of aggregate data. J Am Heart Assoc. 2020;9: e014954.","journal-title":"J Am Heart Assoc"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01762-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-025-01762-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01762-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T17:03:03Z","timestamp":1751043783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-025-01762-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s11604-025-01762-0","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional ethics committee approved this retrospective study protocol (Ehime Prefectural Central Hospital, No. 05-30).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The need for informed consent was waived because of the retrospective observational nature of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}